Celsion Corporation

(CLSN) Trade

By |

Profile

Celsion Corp is a fully-integrated oncology drug development company. It is engaged in developing a portfolio of cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies.

Contact Information

Website: www.celsion.com
Main Phone: +1 609 896-9100
Address: 997 Lenox Drive
Address 2: Suite 100
State: NJ
City / Town: Lawrenceville
Country: USA
Postal Code: 08648

Issuer Information

Exchange: NSC
CEO: Michael H. Tardugno
Employees: 21
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 3.15 $ -0.12 (-3.67%)
Last Price 3.15 Change $ -0.12 Change % -3.67 Tick N/A
Bid 3.15 Bid Size 500.00 Ask 3.17 Ask Size 200.00
Open 3.30 High 3.31 Low 3.10 Prev Close 3.27
Last Trade Volume 364,734 52 Wk Hi 6.06 52 Wk Low 1.24
Market Cap 55.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 17,652,313.00 EPS (TTM) -1.42 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 13 20
Number of Buys 13 20
Number of Sells 0 0
Net Activity 1918750 1966018
Last 10 Buys Shares
Michael H. Tardugno 1,000
Michael H. Tardugno 1,000
Alberto Martinez 1,000
Frederick J. Fritz 1,000
Robert Hooper 1,000
Frederick J. Fritz 1,000
Frederick J. Fritz 1,000
Frederick J. Fritz 1,000
Alberto Martinez 1,000
Alberto Martinez 1,000
Last 10 Sell Shares
Gregory L. Weaver 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 9 9 9 9
Low Target Price Estimate 7 7 7 7
Mean Target Price Estimate 8.33 8.33 8.33 8.33
Standard Deviation 1.15 1.15 1.15 1.15
Date of Most Recent Estimate 03/06/18 03/06/18 03/06/18 03/06/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1